Summary:
Clinical Trials of Texas, Inc. (CTT) is conducting a research study for individuals with Bipolar 1 Disorder who are currently in a depressive episode. The study will be testing the safety and effectiveness of an investigational medication when compared to a placebo (inactive substance). In this research study, the investigational medication is being tested to see when taken at bedtime, it will decrease the symptoms of depression associated with bipolar 1 disorder.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Currently be depressed
•
Be taking medication for bipolar disorder
• Additional criteria may apply
Qualified Participants May Receive:
Study-related medical care from a board-certified psychiatrist, diagnostic testing, study medication and study exams at no cost. Compensation may be available for time and travel.